| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1092852900028856 |
| P698 | PubMed publication ID | 15529089 |
| P2093 | author name string | Ashwin A Patkar | |
| Prakash S Masand | |||
| Farhan S Fazal | |||
| P2860 | cites work | Use of lithium, carbamazepine, and valproic acid in a state-operated psychiatric hospital. | Q33557600 |
| Short-term and long-term treatment for bipolar patients: beyond the guidelines | Q33747481 | ||
| A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| The continuing epidemics of obesity and diabetes in the United States | Q56890709 | ||
| A 10-year follow-up study of tardive dyskinesia | Q67524520 | ||
| Tardive dyskinesia in bipolar affective disorder: a catchment area study | Q68307654 | ||
| Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity | Q71899836 | ||
| Pharmacologic agents for the treatment of acute bipolar mania. | Q34052819 | ||
| Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study | Q34088923 | ||
| Olanzapine-associated diabetes mellitus | Q34139774 | ||
| Risk factors for vascular disease in patients with diabetes | Q34157757 | ||
| The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence | Q34185336 | ||
| Lamotrigine: a review of its use in bipolar disorder | Q34228876 | ||
| Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia | Q34507860 | ||
| Open-label adjunctive topiramate in the treatment of bipolar disorders. | Q34509360 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Treatment research in bipolar disorder: issues and recommendations | Q34969649 | ||
| Review of the use of topiramate for treatment of bipolar disorders | Q35010139 | ||
| Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review | Q35075413 | ||
| Valproate | Q35142736 | ||
| Risperidone-associated diabetes mellitus: a pharmacovigilance study | Q35160244 | ||
| Which antidepressants flick the switch? | Q35182108 | ||
| Social and economic burden of mood disorders | Q35189625 | ||
| Safety and tolerability of lamotrigine for bipolar disorder | Q35645906 | ||
| A review of acute treatments for bipolar depression | Q35755527 | ||
| A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. | Q35854908 | ||
| Atypical Antipsychotics and Glucose Dysregulation: A Series of 4 Cases | Q39853675 | ||
| Lithium and body weight gain. | Q40453474 | ||
| Pathophysiology of insulin resistance in human disease. | Q40453488 | ||
| Rate-corrected QT interval: techniques and limitations | Q40788117 | ||
| Patient and physician attitudes toward lithium: relationship to compliance | Q41666337 | ||
| Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients | Q41671806 | ||
| A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder | Q42629774 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 | ||
| Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study | Q43910389 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes | Q44225722 | ||
| Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics | Q44299750 | ||
| Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children | Q44305298 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Acute and continuation risperidone monotherapy in mania. | Q44723795 | ||
| Factors in antipsychotic drug selection: tolerability considerations | Q44773050 | ||
| Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder. | Q44962387 | ||
| Cardiovascular side effects of novel antipsychotics | Q45029832 | ||
| Quality of life issues associated with antipsychotic-induced weight gain | Q47441133 | ||
| Use of topiramate, a new anti-epileptic as a mood stabilizer | Q48777380 | ||
| The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial. | Q51944305 | ||
| P433 | issue | 11 Suppl 12 | |
| P921 | main subject | bipolar disorder | Q131755 |
| pharmacotherapy | Q701216 | ||
| P304 | page(s) | 16-26 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | C N S Spectrums | Q15750260 |
| P1476 | title | Safety considerations in pharmacotherapy of bipolar disorder | |
| P478 | volume | 9 |
Search more.